Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

NCT06167395 | Completed DMC

• 1 other identifier: UCAMCFE-00031
• Study Type: interventional
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a sustained release beta alanine on the aerobic performance efficacy in recreational cyclist

Conditions

Beta Alanine Supplementation

Keywords

Aerobic Performance; Beta Alanine; Supplementation

Outcome Measures

Primary Outcomes (2)

• Power

  Measured using a cyclus 2 roller.

  Change in performance after 30 days of product consumption

• Distance

  Measured using a cyclus 2 roller.

  Change in performance after 30 days of product consumption

Secondary Outcomes (7)

• Anaerobic treshold

  It will be measured twice, once at baseline or at the end of the study after 30 days.

• Maximum oxygen consumption

  It will be measured twice, once at baseline or at the end of the study after 30 days.

• Aerobic threshold

  It will be measured twice, once at baseline or at the end of the study after 30 days.

• Microcapillary blood

  It will be measured twice, once at baseline or at the end of the study after 30 days.

• Lactate

  It will be measured twice, once at baseline or at the end of the study after 30 days.

Study Arms (3)

Beta Alanine high dose

EXPERIMENTAL

Consumption for 30 days.

Dietary Supplement: Beta Alanine high dose

Beta Alanine low dose

EXPERIMENTAL

Consumption for 30 days.

Dietary Supplement: Beta Alanine low dose

Control group

PLACEBO COMPARATOR

Consumption for 30 days.

Dietary Supplement: Control product

Interventions

Beta Alanine high dose DIETARY_SUPPLEMENT

Subjects should consume 4 intakes of 5 g of beta alanine every 3 hours each day.

Beta Alanine high dose

Beta Alanine low dose DIETARY_SUPPLEMENT

Subjects should consume 4 intakes of 2,5 g of beta alanine every 3 hours each day.

Beta Alanine low dose

Control product DIETARY_SUPPLEMENT

Subjects should consume 4 intakes of 2,5 g of wheat semolina every 3 hours each day.

Control group

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: male
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Male cyclists with more than two years of cycling experience.
• Perform tests without fatigue.
• Road bike training at least twice a week.

You may not qualify if:

• Participants with chronic illness.
• Have a long-term injury that prevents you from training in the previous month.
• Inability to understand informed consent.
• Have consumed beta alanine in the three years prior to the start of the study.
• Consumption of other supplements that may alter performance.

Sponsors & Collaborators

• Universidad Católica San Antonio de Murcia: lead

Study Sites (1)

Catholic University of Murcia

Murcia, 30107, Spain

Location

MeSH Terms

Interventions

beta-Alanine; Control Groups

Intervention Hierarchy (Ancestors)

Alanine; Amino Acids; Amino Acids, Peptides, and Proteins; Epidemiologic Research Design; Epidemiologic Methods; Investigative Techniques; Research Design; Methods

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 2, 2023
• First Posted: December 12, 2023
• Study Start: December 4, 2023
• Primary Completion: February 19, 2024
• Study Completion: March 29, 2024
• Last Updated: May 17, 2024

Record last verified: 2023-11

Locations

ES (1)